Market Overview

Reports: Charles Schwab Looking To Acquire TD Ameritrade For $26B

Share:
Reports: Charles Schwab Looking To Acquire TD Ameritrade For $26B

Charles Schwab (NYSE: SCHW) is looking to acquire TD Ameritrade (NASDAQ: AMTD) for $26 billion, Fox Business first reported. The deal could be announced as soon as today.

In October, Charles Schwab announced it would be slashing its trading commission costs from $4.95 to zero. Brokerages like Fidelity and TD Ameritrade soon followed and also cut fees.

"Not charging for trades is a boon for consumers, but it’s left the brokerages scrambling to find ways to maintain profits," CNBC's Becky Quick reported Thursday morning. "A deal between Schwab and TD Ameritrade would create a behemoth with $5 trillion in combined assets."

See Also: How And Why Are Online Brokers Offering Commission-Free Trades?

Schwab’s founder Charles Schwab told CNBC in October consolidation in the retail brokerage industry is a “logical conclusion that will occur.”

TD Ameritrade's stock traded higher by 25% at $51.85 in Thursday’s pre-market session. The company has a market cap of $22.4 billion.

Charles Schwab shares traded up 12% at $50.09 in Thursday’s pre-market session. The company has a market cap of $57.4 billion.

E*TRADE Financial Corp (NASDAQ:FTFC) fell about 5% at time of publication.

Posted-In: CNBC Fidelity Fox BusinessM&A News Top Stories Media Best of Benzinga

 

Related Articles (AMTD + ETFC)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

30 Stocks Moving in Thursday's Pre-Market Session

The Daily Biotech Pulse: Patent Win For Cellectis, Hepion Proves Efficacy In Animal Model, Job Cuts At Neon